TGFB1 and lupus nephritis: Systemic TGF-β overexpression has been shown to have an inhibitory effect in various autoimmune diseases, including spontaneous lupus nephritis [21], autoimmune encephalomyelitis [22], insulitis in NOD mice [23], and erosive arthritis [24].